Literature DB >> 3940611

An analysis of 1539 patients with cancer of unknown primary site.

E Altman, E Cadman.   

Abstract

A retrospective review of 1539 patients with cancer of unknown primary site seen at Yale-New Haven Hospital from 1922 to 1981 was performed. Information was obtained from the Tumor Registry. The method of diagnosis, patient characteristics, year of diagnosis, histologic features, treatment received, and survival were analyzed. The most common cell type was adenocarcinoma. Survival overall was poor, with a median survival of 5 months for the entire group. Age and year of diagnosis did not appear to significantly influence survival. Closer examination of a small subset of those patients with squamous cell carcinoma revealed a very high male:female ratio, possibly related to tobacco and alcohol abuse. Nearly 9% of these patients were found to have a history of one or more unrelated malignancies.

Entities:  

Mesh:

Year:  1986        PMID: 3940611     DOI: 10.1002/1097-0142(19860101)57:1<120::aid-cncr2820570124>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  In search of the unknown primary.

Authors:  C Bradley; P Selby
Journal:  BMJ       Date:  1992-04-25

2.  Cancer of unknown primary site.

Authors:  J E Ultmann
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Tumour marker immunoreactivity in adenocarcinoma.

Authors:  I O Ellis; A Hitchcock
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

4.  Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case report.

Authors:  Ana Cebollero DE Miguel; Roberto Pazo Cid; Javier Martinez Trufero; Isabel Pajares Bernad; Lourdes Calera Urquizu; Jorge Hernando Cubero; Antonio Anton Torres
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

5.  [Cancer of unknown primary. Epidemiology and pathogenesis].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

6.  Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.

Authors:  Kai Neben; Gerdt Hübner; Gunnar Folprecht; Dirk Jäger; Alwin Krämer
Journal:  Dtsch Arztebl Int       Date:  2008-10-24       Impact factor: 5.594

7.  Unknown primary adenocarcinomas: a single-center experience.

Authors:  Sernaz Uzunoglu; Bulent Erdogan; Hilmi Kodaz; Ahmet Cinkaya; Esma Turkmen; Ilhan Hacibekiroglu; Ali Sari; Alaattin Ozen; Ufuk Usta; Irfan Cicin
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

8.  Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Authors:  Vikas Prasad; Valentina Ambrosini; Merten Hommann; Dieter Hoersch; Stefano Fanti; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

9.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  Long-term survival after incomplete resection of immunohistochemically diagnosed T0N1 lung cancer: report of a case.

Authors:  Yotaro Izumi; Makio Mukai; Koji Kikuchi; Koichi Kobayashi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.